Process Development is the application of chemistry to the scale up of new synthetic processes from the laboratory, through pilot plant to full scale commercial manufacture and into life cycle management. It is an extremely broad discipline, crossing the boundaries between synthetic organic chemistry, process technology and chemical engineering. The area of Process Development continues to be a challenging and important area for the research into and application of modern synthetic organic chemistry, as well as enabling technologies.
The symposium aims to bring together a wide range of speakers from across the Pharmaceutical, Agrochemical and Fine Chemical industries, as well as from an academic background. This meeting brings together experts from across the entire spectrum of the discipline to present state of the art process development.
For further information and prices please email email@example.com
The Identification of Naloxone Related Drug Product Degradants
Dr John Carey, Indivior, UK
Process Chemistry & Catalysis at Roche - Capabilities and selected Case Studies
Dr Stefan Hildbrand, F. Hoffmann-La Roche Ltd.
A long journey into MCL-1 inhibitors
Dr Matthieu Jouffroy, Janssen Pharmaceutica N.V., Belgium
Accelerating chemical process development through data science
Dr Jason M Stevens, Bristol Myers Squibb, USA
Angle control and synergistic promotion strategies in asymmetric catalysis
Prof Wanbin Zhang, Jiao Tong University, China
Ulrich Scholz, Boehringer Ingelheim
Dr Tom Corrie, Syngenta, UK
SCI Members attending this meeting are able to claim CPD points.
Max Espensen, Pharmaron
Louis Diorazio, SCI/AstraZeneca
Dave Lathbury, SCI/Astute Chemical Development Ltd
David Pascoe, SCI/GlaxoSmithKline
Hazmi Tajuddin, SCI/Syngenta
Robert Walton, SCI/Pfizer
Hilmar Weinman, Janssen Pharmaceutical Companies of Johnson & Johnson